The 2026 ESMO annual meeting featured a germ cell tumor rapid oral session and a presentation by Dr. Darren Feldman ...
Circulating tumor DNA/urinary tumor DNA will be collected for retrospective analysis. As of October 21, 2026, EV-309 is ...
(UroToday.com) The 2026 European Society of Medical Oncology (ESMO) Annual Congress held the session: Genitourinary tumour, ...
(UroToday.com) The 2026 ESMO annual meeting featured a prostate cancer session and a presentation by Dr. Neal Shore ...
DLL3 PET provides a non-invasive, whole-body assessment of neuroendocrine differentiation and spatial tumor heterogeneity in ...
This analysis included 58 patients treated with gemcitabine intravesical system monotherapy in the SunRISe-1 cohort who had ...
Using PHS as a continuous variable, 24 week maximally changed cognitive domain in CANTAB showed no significant correlation ...
Twenty patients with metastatic chRCC received first-line lenvatinib plus pembrolizumab. The median age was 63 years, and all ...
(UroToday.com) The 2026 ESMO annual meeting featured a prostate cancer session and a presentation by Dr. Ricardo ...
(UroToday.com) The 2026 North Central Section of the AUA annual meeting featured a prostate cancer session and a presentation ...
The 2026 North Central Section of the AUA annual meeting featured a urothelial carcinoma session and a presentation by Dr.
The 2026 North Central Section of the AUA annual meeting featured a bladder cancer session and a presentation by Dr. Kaitlin Davis discussing regional disparities in bladder cancer mortality rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results